Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
27.92K 25.05K 40.01K 69.17K
Gross Profit
-27.92K -25.05K -40.01K -69.17K
Operating Income
-7.97M -8.66M -10.87M -11.95M
Interest Income
n/a n/a n/a n/a
Pretax Income
-15.04M -120K -10.83M -11.99M
Net Income
-15.04M -120K -10.83M -11.99M
Selling & General & Admin
4.43M 4.51M 5.49M 5.04M
Research & Development
3.55M 4.15M 5.38M 6.92M
Other Expenses
n/a n/a 1K -1K
Operating Expenses
7.97M 8.66M 10.87M 11.95M
Interest Expense
n/a n/a n/a 41.76K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
7.97M 8.66M 10.87M 11.95M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
171.51K 14.29K 1.12K 587.58
Shares Outstanding (Diluted)
171.51K 14.29K 1.12K 587.58
EPS (Basic)
-87.68 -8.41 -9.64K -20.4K
EPS (Diluted)
-87.68 -8.41 -9.64K -20.4K
EBITDA
-7.95M -8.63M -10.84M -11.93M
EBIT
-7.97M -8.66M -10.87M -11.95M
Depreciation & Amortization
27.92K 25.05K 25.05K 16.78K